▶ 調査レポート

世界のワクチンデリバリー市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Vaccines Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のワクチンデリバリー市場 2021:企業別、地域別、種類・用途別 / Global Vaccines Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A11983資料のイメージです。• レポートコード:GIR-107A11983
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、84ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ワクチンデリバリーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ワクチンデリバリーの種類別市場規模(生物学的ベクター、化学担体、その他)、用途別市場規模(病院、クリニック、研究センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・ワクチンデリバリーの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Becton Dickinson and Company (BD)、BioCSL、Novavax Inc.、Vaxart Inc.、Vaxxas、Echo Therapeutics
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:生物学的ベクター、化学担体、その他
・用途別分析2016年-2026年:病院、クリニック、研究センター
・ワクチンデリバリーの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ワクチンデリバリーのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ワクチンデリバリーのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ワクチンデリバリーの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ワクチンデリバリーの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Vaccines Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vaccines Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Vaccines Delivery market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Vaccines Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Biological Vector
Chemical Carrier
Others

Market segment by Application, can be divided into
Hospital
Clinic
Research Center

Market segment by players, this report covers
Becton Dickinson and Company (BD)
BioCSL
Novavax Inc.
Vaxart Inc.
Vaxxas
Echo Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Vaccines Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Vaccines Delivery, with revenue, gross margin and global market share of Vaccines Delivery from 2019 to 2021.
Chapter 3, the Vaccines Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Vaccines Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Vaccines Delivery research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Vaccines Delivery
1.2 Classification of Vaccines Delivery by Type
1.2.1 Overview: Global Vaccines Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Vaccines Delivery Revenue Market Share by Type in 2020
1.2.3 Biological Vector
1.2.4 Chemical Carrier
1.2.5 Others
1.3 Global Vaccines Delivery Market by Application
1.3.1 Overview: Global Vaccines Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Vaccines Delivery Market Size & Forecast
1.5 Global Vaccines Delivery Market Size and Forecast by Region
1.5.1 Global Vaccines Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Vaccines Delivery Market Size by Region, (2016-2021)
1.5.3 North America Vaccines Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Vaccines Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Vaccines Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Vaccines Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Vaccines Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccines Delivery Market Drivers
1.6.2 Vaccines Delivery Market Restraints
1.6.3 Vaccines Delivery Trends Analysis
2 Company Profiles
2.1 Becton Dickinson and Company (BD)
2.1.1 Becton Dickinson and Company (BD) Details
2.1.2 Becton Dickinson and Company (BD) Major Business
2.1.3 Becton Dickinson and Company (BD) Vaccines Delivery Product and Solutions
2.1.4 Becton Dickinson and Company (BD) Vaccines Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Becton Dickinson and Company (BD) Recent Developments and Future Plans
2.2 BioCSL
2.2.1 BioCSL Details
2.2.2 BioCSL Major Business
2.2.3 BioCSL Vaccines Delivery Product and Solutions
2.2.4 BioCSL Vaccines Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioCSL Recent Developments and Future Plans
2.3 Novavax Inc.
2.3.1 Novavax Inc. Details
2.3.2 Novavax Inc. Major Business
2.3.3 Novavax Inc. Vaccines Delivery Product and Solutions
2.3.4 Novavax Inc. Vaccines Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novavax Inc. Recent Developments and Future Plans
2.4 Vaxart Inc.
2.4.1 Vaxart Inc. Details
2.4.2 Vaxart Inc. Major Business
2.4.3 Vaxart Inc. Vaccines Delivery Product and Solutions
2.4.4 Vaxart Inc. Vaccines Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Vaxart Inc. Recent Developments and Future Plans
2.5 Vaxxas
2.5.1 Vaxxas Details
2.5.2 Vaxxas Major Business
2.5.3 Vaxxas Vaccines Delivery Product and Solutions
2.5.4 Vaxxas Vaccines Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Vaxxas Recent Developments and Future Plans
2.6 Echo Therapeutics
2.6.1 Echo Therapeutics Details
2.6.2 Echo Therapeutics Major Business
2.6.3 Echo Therapeutics Vaccines Delivery Product and Solutions
2.6.4 Echo Therapeutics Vaccines Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Echo Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vaccines Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Vaccines Delivery Players Market Share
3.2.2 Top 10 Vaccines Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Vaccines Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Vaccines Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Vaccines Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Vaccines Delivery Revenue Market Share by Application (2016-2021)
5.2 Vaccines Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Vaccines Delivery Revenue by Type (2016-2026)
6.2 North America Vaccines Delivery Revenue by Application (2016-2026)
6.3 North America Vaccines Delivery Market Size by Country
6.3.1 North America Vaccines Delivery Revenue by Country (2016-2026)
6.3.2 United States Vaccines Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Vaccines Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Vaccines Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Vaccines Delivery Revenue by Type (2016-2026)
7.2 Europe Vaccines Delivery Revenue by Application (2016-2026)
7.3 Europe Vaccines Delivery Market Size by Country
7.3.1 Europe Vaccines Delivery Revenue by Country (2016-2026)
7.3.2 Germany Vaccines Delivery Market Size and Forecast (2016-2026)
7.3.3 France Vaccines Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Vaccines Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Vaccines Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Vaccines Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Vaccines Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Vaccines Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Vaccines Delivery Market Size by Region
8.3.1 Asia-Pacific Vaccines Delivery Revenue by Region (2016-2026)
8.3.2 China Vaccines Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Vaccines Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Vaccines Delivery Market Size and Forecast (2016-2026)
8.3.5 India Vaccines Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Vaccines Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Vaccines Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Vaccines Delivery Revenue by Type (2016-2026)
9.2 South America Vaccines Delivery Revenue by Application (2016-2026)
9.3 South America Vaccines Delivery Market Size by Country
9.3.1 South America Vaccines Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Vaccines Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Vaccines Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Vaccines Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Vaccines Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Vaccines Delivery Market Size by Country
10.3.1 Middle East & Africa Vaccines Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Vaccines Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Vaccines Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Vaccines Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Vaccines Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Vaccines Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Vaccines Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Vaccines Delivery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Vaccines Delivery Revenue Market Share by Region (2021-2026)
Table 6. Becton Dickinson and Company (BD) Corporate Information, Head Office, and Major Competitors
Table 7. Becton Dickinson and Company (BD) Major Business
Table 8. Becton Dickinson and Company (BD) Vaccines Delivery Product and Solutions
Table 9. Becton Dickinson and Company (BD) Vaccines Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioCSL Corporate Information, Head Office, and Major Competitors
Table 11. BioCSL Major Business
Table 12. BioCSL Vaccines Delivery Product and Solutions
Table 13. BioCSL Vaccines Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novavax Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Novavax Inc. Major Business
Table 16. Novavax Inc. Vaccines Delivery Product and Solutions
Table 17. Novavax Inc. Vaccines Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Vaxart Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Vaxart Inc. Major Business
Table 20. Vaxart Inc. Vaccines Delivery Product and Solutions
Table 21. Vaxart Inc. Vaccines Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Vaxxas Corporate Information, Head Office, and Major Competitors
Table 23. Vaxxas Major Business
Table 24. Vaxxas Vaccines Delivery Product and Solutions
Table 25. Vaxxas Vaccines Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Echo Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Echo Therapeutics Major Business
Table 28. Echo Therapeutics Vaccines Delivery Product and Solutions
Table 29. Echo Therapeutics Vaccines Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Vaccines Delivery Revenue (USD Million) by Players (2019-2021)
Table 31. Global Vaccines Delivery Revenue Share by Players (2019-2021)
Table 32. Breakdown of Vaccines Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Vaccines Delivery Players Head Office, Products and Services Provided
Table 34. Vaccines Delivery Mergers & Acquisitions in the Past Five Years
Table 35. Vaccines Delivery New Entrants and Expansion Plans
Table 36. Global Vaccines Delivery Revenue (USD Million) by Type (2016-2021)
Table 37. Global Vaccines Delivery Revenue Share by Type (2016-2021)
Table 38. Global Vaccines Delivery Revenue Forecast by Type (2021-2026)
Table 39. Global Vaccines Delivery Revenue by Application (2016-2021)
Table 40. Global Vaccines Delivery Revenue Forecast by Application (2021-2026)
Table 41. North America Vaccines Delivery Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Vaccines Delivery Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Vaccines Delivery Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Vaccines Delivery Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Vaccines Delivery Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Vaccines Delivery Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Vaccines Delivery Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Vaccines Delivery Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Vaccines Delivery Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Vaccines Delivery Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Vaccines Delivery Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Vaccines Delivery Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Vaccines Delivery Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Vaccines Delivery Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Vaccines Delivery Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Vaccines Delivery Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Vaccines Delivery Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Vaccines Delivery Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Vaccines Delivery Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Vaccines Delivery Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Vaccines Delivery Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Vaccines Delivery Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Vaccines Delivery Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Vaccines Delivery Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Vaccines Delivery Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Vaccines Delivery Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Vaccines Delivery Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Vaccines Delivery Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Vaccines Delivery Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Vaccines Delivery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Vaccines Delivery Picture
Figure 2. Global Vaccines Delivery Revenue Market Share by Type in 2020
Figure 3. Biological Vector
Figure 4. Chemical Carrier
Figure 5. Others
Figure 6. Vaccines Delivery Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Research Center Picture
Figure 10. Global Vaccines Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Vaccines Delivery Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Vaccines Delivery Revenue Market Share by Region (2016-2026)
Figure 13. Global Vaccines Delivery Revenue Market Share by Region in 2020
Figure 14. North America Vaccines Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Vaccines Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Vaccines Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Vaccines Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Vaccines Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Vaccines Delivery Market Drivers
Figure 20. Vaccines Delivery Market Restraints
Figure 21. Vaccines Delivery Market Trends
Figure 22. Becton Dickinson and Company (BD) Recent Developments and Future Plans
Figure 23. BioCSL Recent Developments and Future Plans
Figure 24. Novavax Inc. Recent Developments and Future Plans
Figure 25. Vaxart Inc. Recent Developments and Future Plans
Figure 26. Vaxxas Recent Developments and Future Plans
Figure 27. Echo Therapeutics Recent Developments and Future Plans
Figure 28. Global Vaccines Delivery Revenue Share by Players in 2020
Figure 29. Vaccines Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Vaccines Delivery Revenue Market Share in 2020
Figure 31. Global Top 10 Players Vaccines Delivery Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Vaccines Delivery Revenue Share by Type in 2020
Figure 34. Global Vaccines Delivery Market Share Forecast by Type (2021-2026)
Figure 35. Global Vaccines Delivery Revenue Share by Application in 2020
Figure 36. Global Vaccines Delivery Market Share Forecast by Application (2021-2026)
Figure 37. North America Vaccines Delivery Sales Market Share by Type (2016-2026)
Figure 38. North America Vaccines Delivery Sales Market Share by Application (2016-2026)
Figure 39. North America Vaccines Delivery Revenue Market Share by Country (2016-2026)
Figure 40. United States Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Vaccines Delivery Sales Market Share by Type (2016-2026)
Figure 44. Europe Vaccines Delivery Sales Market Share by Application (2016-2026)
Figure 45. Europe Vaccines Delivery Revenue Market Share by Country (2016-2026)
Figure 46. Germany Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Vaccines Delivery Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Vaccines Delivery Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Vaccines Delivery Revenue Market Share by Region (2016-2026)
Figure 54. China Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Vaccines Delivery Sales Market Share by Type (2016-2026)
Figure 61. South America Vaccines Delivery Sales Market Share by Application (2016-2026)
Figure 62. South America Vaccines Delivery Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Vaccines Delivery Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Vaccines Delivery Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Vaccines Delivery Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Vaccines Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source